From 20 October till 24 October 2023: HIGHLIGHTS FROM ESMO

Your direct line with Madrid

The European Society of Medical Oncology (ESMO) 2023 brings together leading experts in the different fields of cancer from around the world. And this year they gather together in Madrid, Spain. The MediMix team is also onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen. And, we dive into posters and hot topics with the experts as they are being presented.

Stay tuned, and get ready for an exciting and informative journey!

With the educational support of:

Daily highlights in head & neck

Daily highlight in head and neck cancer

The GORTEC 2014-04 trial sought to assess the efficacy of omitting chemotherapy after Stereotactic Ablative Radiotherapy (SABR) in first-line treatment for metastatic head and neck cancer patients. The study enrolled

See video »

In-depth stories about head & neck

The LIBRETTO-531 study

LIBRETTO-531, a phase 3 trial, was designed to establish the optimal first-line regimen for advanced RET-mutant MTC. Experts are deliberating the necessity of a large-scale global phase 3 study, especially

See video »

Head & neck poster selection

With the educational support of:

Z1. Researchpark 30, 1731 Zellik, Belgium
Website created by MediMix © 2023 - Privacy Policy